- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 88,090 | 29.05.24 20:09:21 | -0,770 | -0,87% | 87,460 | 87,610 | 87,800 | 88,090 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 895,000 | 29.05.24 18:20:50 | -6,200 | -0,69% | 884,600 | 890,600 | 888,200 | 895,000 |
